secwatch.observer — SEC 8-K summary
======================================

Issuer:     International Stem Cell CORP (ISCO)
CIK:        0001355790
Form:       8-K
Filed at:   2024-09-17T23:59:59+00:00
Accession:  0001683168-24-006436
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

International Stem Cell extends CEO's $2.7M loan maturity to Sept 2025 after repaying $200k
--------------------------------------------------------------------------------

- CEO Dr. Andrey Semechkin loan of $2.9M extended; $200k repaid, new $2.7M unsecured note issued.
- New note bears 5.5% interest, matures Sept 15, 2025, prepayable without penalty.
- Accrued unpaid interest of ~$645k from prior note remains outstanding.
- Related-party transaction creates direct financial obligation; Noteholder is Co-Chairman and CEO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1355790/000168316824006436/0001683168-24-006436-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1355790/000168316824006436/intlstemcell_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-006436

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer